These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1907241)

  • 1. Cost-utility analysis of thrombolytic therapy.
    Simoons ML; Vos J; Martens LL
    Eur Heart J; 1991 Jun; 12(6):694-9. PubMed ID: 1907241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
    Vermeer F; Simoons ML; de Zwaan C; van Es GA; Verheugt FW; van der Laarse A; van Hoogenhuyze DC; Azar AJ; van Dalen FJ; Lubsen J
    Br Heart J; 1988 May; 59(5):527-34. PubMed ID: 3132962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term follow-up of thrombolytic treatment of acute infarct in combination with acute and elective revascularization].
    Spiecker M; Erbel R; Diefenbach C; Haidasch M; Treese N; Henrichs KJ; Rupprecht HJ; Pop T; Iversen S; Oelert H
    Med Klin (Munich); 1992 Jul; 87(7):343-9. PubMed ID: 1508114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.
    Mark DB; O'Neill WW; Brodie B; Ivanhoe R; Knopf W; Taylor G; O'Keefe JH; Grines CL; Davidson-Ray L; Knight JD
    J Am Coll Cardiol; 1995 Sep; 26(3):688-95. PubMed ID: 7642860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and quality of life: thrombolysis and primary angioplasty.
    Goldman L
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):38S-41S. PubMed ID: 7775713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
    Bøhmer E; Kristiansen IS; Arnesen H; Halvorsen S
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L; Simek S; Linhart A; Cahlík T; Palecek T; Lubanda JC; Korínek J; Beran S; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):97-102. PubMed ID: 12728575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.
    Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB
    Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction.
    Boersma H; van der Vlugt MJ; Arnold AE; Deckers JW; Simoons ML
    Eur Heart J; 1996 Jan; 17(1):64-75. PubMed ID: 8682132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary PTCA versus thrombolysis with tPA in acute myocardial infarction: a formal cost-effectiveness analysis.
    Müllner M; Paulis M; Nikfardjam M; Domanovits H; Huber K
    Wien Klin Wochenschr; 1999 Jan; 111(1):37-41. PubMed ID: 10067269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracoronary thrombolytic therapy of myocardial infarction].
    Khalfen ESh; Shtern SV
    Ter Arkh; 1985; 57(5):79-84. PubMed ID: 3927500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness model for coronary thrombolysis/reperfusion therapy.
    Laffel GL; Fineberg HV; Braunwald E
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):79B-90B. PubMed ID: 2959718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and efficacy of intravenous streptokinase plus PTCA for acute myocardial infarction when therapy is initiated in community hospitals.
    Leimbach WN; Hagan AD; Vaughan HL; Sonnenschein RC; McCoy JD; Basta LL
    Clin Cardiol; 1988 Nov; 11(11):731-8. PubMed ID: 2976624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in acute myocardial infarction.
    Simoons ML
    Annu Rev Med; 1989; 40():181-200. PubMed ID: 2524993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolysis in acute myocardial infarct. An improved long-term prognosis following balloon dilatation].
    Schwarz F; König B; Tillmanns H; Schuler G; Manthey J; Dietz R; Kübler W; Olschewski M; Scheurlen H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):331-4. PubMed ID: 2949964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.
    Grines C; Patel A; Zijlstra F; Weaver WD; Granger C; Simes RJ;
    Am Heart J; 2003 Jan; 145(1):47-57. PubMed ID: 12514654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after intracoronary streptokinase therapy for acute myocardial infarction.
    Blanke H; Schicha H; Cohen M; Kaiser H; Karsch KR; Neumann P; Rentrop KP
    Bibl Cardiol; 1985; (39):65-76. PubMed ID: 3879851
    [No Abstract]   [Full Text] [Related]  

  • 20. Sion thrombolysis trial--randomised trial of intravenous thrombolysis & primary percutaneous transluminal coronary angioplasty for acute myocardial infarction [AMI]--feasibility phase data of angioplasty limb.
    Mehta AB; Abhyankar AD
    J Assoc Physicians India; 1994 Jan; 42(1):43-4. PubMed ID: 7836249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.